Long Term Beta Thalassemia Treatment: Findings From The Extension Period

Clinical trial NCT06490601 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06490601
Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Fetal Hemoglobin Beta-Thalassemia Hemoglobinopathies

Start date: 2022-04-01
Primary completion: 2024-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.